Revolution Medicines Inc. Common Stock vs SentinelOne Inc. Class A Common Stock — how do they compare? Revolution Medicines Inc. Common Stock trades at $189 (market cap $43.07B), while SentinelOne Inc. Class A Common Stock trades at $25.28 (market cap $8.81B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 4.9× SentinelOne Inc. Class A Common Stock's market cap, and SentinelOne Inc. Class A Common Stock is trading nearer its 52-week high, Revolution Medicines Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and SentinelOne Inc. Class A Common Stock for 0 Days on average.
| RVMD | S | |
|---|---|---|
Market Cap | $43.07B | $8.81B |
Volume | 1,184,841 | 8,035,068 |
Sector | Health | Technology |
52-Week High | $221.15 | $25.80 |
52-Week Low | $47.50 | $11.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $39.77B | $8.20B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →SentinelOne provides an AI-powered cybersecurity platform for organizations. Its Singularity platform helps detect, prevent, and respond to threats across endpoints, cloud workloads, identities, and connected devices.
Read more on S →